Spike outside; 0 cases in Bengaluru
Posted 23 Dec, 2022 | Source: https://bangaloremirror.indiatimes.com/
Though there are no covid patients in city’s hospitals as of now, docs advise caution
Foxed by monkeypox?
Posted 21 Aug, 2022 | Source: https://www.deccanherald.com/
While the smallpox vaccine may not protect you from monkeypox forever, the viral illness is self-limiting and gets cured in around three weeks, writes Dr Swati Rajagopal
Right time to get your booster dose? It’s now
Posted 08 Jul, 2022 | Source: bangaloremirror.indiatimes.com
City docs welcome reduction in gap between second dose and booster shot to help increase vax coverage among people in wake of rising covid cases
Two Delta-Omicron co-infection cases found in Bowring, patients discharged
Posted 22 Feb, 2022 | Source: deccanherald.com
The state surveillance unit has been asked to check the genomic sequencing reports of two-third patients who died in January
Covid boosters for 18-60 age group mooted
Posted 19 Jan, 2022 | Source: ewstrailindia.com
Bengaluru: While the State is seeing a rise in the Covid- 19 hospitalisations, mainly among the unvaccinated, the health experts are debating whether it is time to administer a third dose for those in the age group of 18-60 years.
No takers for LOCKDOWN
Posted 17 Jan, 2022 | Source: newstrailindia.com
While the state is on the verge of a third wave, fuelled by the new Covid variant Omicron, both policymakers and health experts are the economy, which has already suffered a lot during the past two waves of Covid-19.
Testing times again
Posted 13 Jan, 2022 | Source: https://bangaloremirror.indiatimes.com/
Palike adopts safe-than-sorry approach, ramps up testing in B’luru to fight the virus
State shy of 1Lactive cases
Posted 13 Jan, 2022 | Source: EXPRESS NEWS SERVICE
Doubling trend points to community spread; Bengaluru has 73,000 active cases
Self-medication with Molnupiravir can be dangerous: Experts
Posted 11 Jan, 2022 | Source: newindianexpress.com
BENGALURU: Though the antiviral drug Molnupiravir has been kept out of the treatment protocol recommended by the Indian Council of Medical Research (ICMR), doctors are warning patients that the drug, which is now available in the market, has “major safety concerns” and should not self-administered.
